论文信息 - Cost per response for abatacept versus adalimumab in patients with seropositive, erosive early rheumatoid arthritis in the US, Germany, Spain, and Canada - 字舞流文

Cost per response for abatacept versus adalimumab in patients with seropositive, erosive early rheumatoid arthritis in the US, Germany, Spain, and Canada

C. Baerwald | M. Bergman | R. Postema | J. Foo | C. Polanco-Sánchez | C. Morel | A. Marshall | J. M. Rodríguez-Heredia